SERPINE1 and neoplasm: Subgroup analysis demonstrated significantly elevated SERPINE1 immunoreactivity scores in advanced pathological stages (III vs. I–II), deeper tumor invasion (T4 vs. T1-3), and extensive nodal metastasis (N2-3 vs. N0-1) (Figs. 7H–7J).